Main Article Content
This paper reports a case of cholestatic type hepatitis A, a rare clinical manifestation of hepatitis A in children. The diagnosis was based on the presence of IgM Anti HAV, symptoms longer than 8 weeks, bilirubin concentration exceeding 10g/dl, and absence of substantial hepatocellular and biliary damage. Corticosteroid therapy resulted in complete recovery.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
2. Sherlock S. Diseases of the Liver. 10th ed. Oxford: Blackwell Scientific Publications; 1996. p. 241-5.
3. Kemmer NM, Miskovsky EP.Infection of the liver, hepatitis A. Infect Dis Clin North Am. 2000;14:1-11.
4. Lemon SM. Type A viral hepatitis. In: Prieto J, Rodes J, Shafritz DA, editors. Hepatobiliary diseases. Berlin Springer Verlag; 1992. p. 495-510.
5. Eisenburg J. Cholestasis guiding symptoms in liver disease. 6th ed. Munich Falk Foundation; 1996. p. 84-5.
6. Mourani S, Dobbs SM, Genta RM, Tandon AK, Yoffe B. Hepatitis A virus-associated cholecystitis. Ann Intern Med 1994; 120:398-400.
7. Gordon SC, Reddy R, Schiff L, Schiff ER. Prolonged intrahepatic cholestasis secondary to acute hepatitis A. Ann Intern Med 1984; 101:635-7.
8. Irving HC, Bates J. Gallbladder and biliary tree. In: Cosgrove D, Meire H, Dewbury K, editors. Abdominal and general ultrasound. 2nd ed. New York: Churchill Livingstone; 1993. p. 171-84.
9. Moseley RH, Gunucio JJ. Cholestatic syndromes. In: Devita VT, Dupont HL, Haris ED, et al editors. Textbook of Internal Medicine. 2nd ed. Philadelphia: JB Lippincott Co; 1992. p. 561-8.
10. Berg CL, Gollan JL. Pharmacotherapy of hepatobiliary disease. In: Wolfe MM, editor. Gastrointestinal pharmacotherapy. 2nd ed. Toronto: WB Saunders Co; 1993. p. 245-58.
11. Narkewicz MR, Smith D, Gregory C, Lear JL, Osberg I, Sokol RJ. Effect of ursodeoxycholic therapy on hepatic function in children with intrahepatic cholestatic liver disease. J Pediatr Gastroenterol Nutr 1998;26:49-55.